| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.6B | $2.0B | $2.0B | $2.1B | $2.2B | $5.0B | $4.2B | — |
| Cost of Revenue | $12.8B | $12.9B | $13.5B | $12.6B | $11.7B | $11.5B | $11.1B | — |
| Gross Profit | $1.5B | $1.7B | $1.7B | $1.8B | $1.6B | $1.8B | $1.5B | $1.4B |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | $3.4B | $3.3B | $3.5B | $3.1B | $3.1B | $3.2B | $2.9B | $2.8B |
| Operating Income | $3.3B | $3.4B | $3.4B | $3.5B | $3.1B | $3.0B | $2.5B | $2.5B |
| Net Income | $0.3B | $0.6B | $0.6B | $0.8B | $0.4B | $0.6B | $0.6B | $0.4B |
| EPS (Basic) | $0.53 | $0.98 | $1.04 | $1.36 | $0.68 | $1.03 | $0.95 | $0.60 |
| EPS (Diluted) | $0.53 | $0.98 | $1.03 | $1.35 | $0.68 | $1.02 | $0.94 | $0.59 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $33.1B | $31.5B | $31.5B | $31.1B | $31.8B | $30.8B | $30.1B | $30.6B |
| Current Assets | $5.3B | $4.6B | $5.2B | $5.1B | $5.8B | $5.1B | $4.2B | $4.1B |
| Cash & Equivalents | $0.4B | $0.4B | $0.6B | $0.6B | $1.5B | $1.7B | $0.5B | $0.4B |
| Total Liabilities | $23.9B | $21.8B | $20.8B | $20.3B | $21.5B | $21.9B | $22.2B | $23.4B |
| Current Liabilities | $7.9B | $7.0B | $7.5B | $8.0B | $8.3B | $7.5B | $7.1B | $7.3B |
| Stockholders' Equity | $9.2B | $9.4B | $10.4B | $10.5B | $9.5B | $8.1B | $7.1B | $6.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.9B | $3.3B | $2.8B | $3.3B | $3.0B | $3.7B | $2.8B | $2.8B |
| Investing Cash Flow | $-1.8B | $-1.2B | $-0.3B | $-1.7B | $-0.5B | $-0.5B | $-0.6B | $-8.7B |
| Capital Expenditures | $0.6B | $0.8B | $0.7B | $0.6B | $0.5B | $0.5B | $0.5B | $0.6B |
| Financing Cash Flow | $-1.2B | $-2.3B | $-2.4B | $-2.5B | $-2.7B | $-1.9B | $-2.2B | $5.4B |